Raising P50 increases tissue PO2 in canine skeletal muscle but does not affect critical O2 extraction ratio.
Affinity of hemoglobin (Hb) for O2 determines in part the rate of O2 diffusion from capillaries to myocytes by altering capillary PO2. We hypothesized that a decrease in Hb O2 affinity (increased P50) would increase capillary and tissue PO2 (PtiO2) and improve O2 consumption during ischemia. To test this hypothesis, blood flow to the pump-perfused left hindlimb of 18 anesthetized and paralyzed dogs was progressively decreased over 90 min while hindlimb O2 consumption and O2 delivery (QO2) and PtiO2 were measured at the muscle surface. Arterial PO2 was maintained at 150 +/- 10 Torr in all dogs. We increased P50 by 12.3 +/- 0.9 (SE) Torr in nine dogs with RSR-13, an allosteric modifier of Hb. This decreased arterial O2 saturation to 90-92% but increased mean PtiO2 from 35.5 +/- 11.6 to 44.1 +/- 15.2 (SD) Torr (P < 0.05) with no change in controls (n = 9). O2 extraction ratio at critical QO2 was 74 +/- 2% in controls and 79 +/- 1% in RSR-13-treated dogs (P = not significant). PtiO2 was 30-40% higher in the RSR-13-treated group at any QO2 above critical but did not differ between groups below critical QO2. Perfusion heterogeneity and convergence of the dissociation curves near critical QO2 may have mitigated any effect of increased P50 on O2 diffusion. Still, increasing P50 by 12 Torr with RSR-13 significantly increased PtiO2 at QO2 values above critical.
Curtis
S E
SE
Department of Pediatrics, University of Alabama at Birmingham 35294, USA.
Walker
T A
TA
Bradley
W E
WE
Cain
S M
SM
D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D000986:Antisickling Agents / Q000494:pharmacology; D002245:Carbon Dioxide / Q000378:metabolism; D004285:Dogs; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D006614:Hindlimb / Q000098:blood supply / Q000502:physiology; D007511:Ischemia / Q000378:metabolism; D008297:Male; D018482:Muscle, Skeletal / Q000098:blood supply / Q000378:metabolism*; D010100:Oxygen / Q000097:blood*; D010101:Oxygen Consumption / Q000502:physiology*; D010108:Oxyhemoglobins / Q000378:metabolism; D010477:Perfusion; D011422:Propionates / Q000494:pharmacology; D012039:Regional Blood Flow / Q000502:physiology
D000814:Aniline Compounds; D000986:Antisickling Agents; D006454:Hemoglobins; D010108:Oxyhemoglobins; D011422:Propionates; D002245:Carbon Dioxide; C067396:efaproxiral; D010100:Oxygen